EPO Patents = 1

Forward Citations = 42

Loading Chart...

9 inventors (with patents filed for the assignee):

Darius Ghaderi (2 out of 2 patents)

Ana Paula Galvao Da Silva (2 out of 2 patents)

Jeffrey Behrens (1 out of 4 patents)

4. Alexey Alexandrovich Lugovskoy (1 out of 50 patents)

5. Julie DeSander (1 out of 2 patents)

6. Ajit Varki (1 out of 11 patents)

7. Richard B Schwab (1 out of 1 patent)

8. Vered Padler-Karavani (1 out of 1 patent)

9. Nancy Hurtado-Ziola (1 out of 1 patent)

10. Richard Schwab (0 patent)

4 patents: Sort by Forward Citations

1. 9879087 - Glycan-interacting compounds and methods of use (2018-01-30),

2. 9423401 - Compositions and methods for detecting cancer (2016-08-23),

3. 9416194 - Glycan-interacting compounds (2016-08-16),

4. 9273142 - Glycan-interacting compounds (2016-03-01),

Siamab Therapeutics, Inc. is a biopharmaceutical company focused on developing novel cancer immunotherapies. They are pioneering the use of antibody-drug conjugates to target and treat a wide range of solid tumors. With a strong pipeline of drug candidates and a team of experienced scientists, Siamab is committed to advancing the field of oncology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#65 in Newton, MA

#3,234 in Massachusetts

#59,049 in US

Newton, MA, United States of America

Siamab Therapeutics, Inc.